{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T07:27:40Z","timestamp":1782458860552,"version":"3.54.5"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T00:00:00Z","timestamp":1570406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["U01HG006379,"],"award-info":[{"award-number":["U01HG006379,"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Center for Individualized Medicine"},{"name":"Center for the Science of Health Care Delivery at Mayo Clinic"},{"name":"Dr. Caraballo","award":["NSF 1602198"],"award-info":[{"award-number":["NSF 1602198"]}]},{"name":"Dr. Caraballo","award":["LM 11972"],"award-info":[{"award-number":["LM 11972"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Pharmacogenomics (PGx) clinical decision support integrated into the electronic health record (EHR) has the potential to provide relevant knowledge to clinicians to enable individualized care. However, past experience implementing PGx clinical decision support into multiple EHR platforms has identified important clinical, procedural, and technical challenges. Commercial EHRs have been widely criticized for the lack of readiness to implement precision medicine. Herein, we share our experiences and lessons learned implementing new EHR functionality charting PGx phenotypes in a unique repository, genomic indicators, instead of using the problem or allergy list. The Gen-Ind has additional features including a brief description of the clinical impact, a hyperlink to the original laboratory report, and links to additional educational resources. The automatic generation of genomic indicators from interfaced PGx test results facilitates implementation and long-term maintenance of PGx data in the EHR and can be used as criteria for synchronous and asynchronous CDS.<\/jats:p>","DOI":"10.1093\/jamia\/ocz177","type":"journal-article","created":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T11:39:26Z","timestamp":1568288366000},"page":"154-158","source":"Crossref","is-referenced-by-count":50,"title":["Integrating pharmacogenomics into the electronic health record by implementing genomic indicators"],"prefix":"10.1093","volume":"27","author":[{"given":"Pedro J","family":"Caraballo","sequence":"first","affiliation":[{"name":"Division of General Internal Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA"},{"name":"Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A","family":"Sutton","sequence":"additional","affiliation":[{"name":"Department of Information Technology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyothsna","family":"Giri","sequence":"additional","affiliation":[{"name":"Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A","family":"Wright","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Services, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne T","family":"Nicholson","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iftikhar J","family":"Kullo","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A","family":"Parkulo","sequence":"additional","affiliation":[{"name":"Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA"},{"name":"Division of Community Internal Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzette J","family":"Bielinski","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann M","family":"Moyer","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,10,7]]},"reference":[{"issue":"1","key":"2020110613080639400_ocz177-B1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.genom.6.080604.162315","article-title":"Pharmacogenetics and pharmacogenomics: development, science, and translation","volume":"7","author":"Weinshilboum","year":"2006","journal-title":"Annu Rev Genom Hum Genet"},{"key":"2020110613080639400_ocz177-B2","year":"2019"},{"issue":"3","key":"2020110613080639400_ocz177-B3","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/clpt.2010.279","article-title":"CPIC: clinical pharmacogenetics implementation consortium of the pharmacogenomics research network","volume":"89","author":"Relling","year":"2011","journal-title":"Clin Pharmacol Ther"},{"issue":"7573","key":"2020110613080639400_ocz177-B4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature15817","article-title":"Pharmacogenomics in the clinic","volume":"526","author":"Relling","year":"2015","journal-title":"Nature"},{"key":"2020110613080639400_ocz177-B5","year":"2019"},{"key":"2020110613080639400_ocz177-B6","year":"2019"},{"key":"2020110613080639400_ocz177-B7","year":"2019"},{"issue":"5","key":"2020110613080639400_ocz177-B8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/cts.12404","article-title":"Implementing pharmacogenomics at your institution: establishment and overcoming implementation challenges","volume":"9","author":"Arwood","year":"2016","journal-title":"Clin Transl Sci"},{"issue":"e1","key":"2020110613080639400_ocz177-B9","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1136\/amiajnl-2013-001993","article-title":"Development and use of active clinical decision support for preemptive pharmacogenomics","volume":"21","author":"Bell","year":"2014","journal-title":"J Am Med Inform Assoc"},{"issue":"4","key":"2020110613080639400_ocz177-B10","doi-asserted-by":"crossref","first-page":"421\u20139.","DOI":"10.1038\/gim.2016.120","article-title":"Multidisciplinary model to implement pharmacogenomics at the point of care","volume":"19","author":"Caraballo","year":"2017","journal-title":"Genet Med"},{"issue":"1","key":"2020110613080639400_ocz177-B11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev-pharmtox-010814-124835","article-title":"Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers","volume":"55","author":"Dunnenberger","year":"2015","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"2","key":"2020110613080639400_ocz177-B12","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/clpt.2013.72","article-title":"The CLIPMERGE PGx program: clinical implementation of personalized medicine through electronic health records and genomics-pharmacogenomics","volume":"94","author":"Gottesman","year":"2013","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"2020110613080639400_ocz177-B13","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/phar.1786","article-title":"Implementation of clinical pharmacogenomics within a large health system: from electronic health record decision support to consultation services","volume":"36","author":"Hicks","year":"2016","journal-title":"Pharmacotherapy"},{"issue":"1","key":"2020110613080639400_ocz177-B14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ajmg.c.31391","article-title":"PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics","volume":"166C","author":"Hoffman","year":"2014","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"7","key":"2020110613080639400_ocz177-B15","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2217\/pgs.13.59","article-title":"Institutional profile: University of Florida and Shands Hospital Personalized Medicine Program: clinical implementation of pharmacogenetics","volume":"14","author":"Johnson","year":"2013","journal-title":"Pharmacogenomics"},{"issue":"4","key":"2020110613080639400_ocz177-B16","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/clpt.2012.117","article-title":"The 1200 patients project: creating a new medical model system for clinical implementation of pharmacogenomics","volume":"92","author":"O'Donnell","year":"2012","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"2020110613080639400_ocz177-B17","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/gim.2013.109","article-title":"Electronic health record design and implementation for pharmacogenomics: a local perspective","volume":"15","author":"Peterson","year":"2013","journal-title":"Genet Med"},{"issue":"1","key":"2020110613080639400_ocz177-B18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/clpt.2011.371","article-title":"Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project","volume":"92","author":"Pulley","year":"2012","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"2020110613080639400_ocz177-B19","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/ajmg.c.31396","article-title":"Implementation of pharmacogenetics: The University of Maryland personalized anti-platelet pharmacogenetics program","volume":"166","author":"Shuldiner","year":"2014","journal-title":"Am J Med Genet"},{"issue":"2","key":"2020110613080639400_ocz177-B20","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/cpt.707","article-title":"Electronic medical record-integrated pharmacogenomics and related clinical decision support concepts","volume":"102","author":"Caraballo","year":"2017","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"2020110613080639400_ocz177-B21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jbi.2006.02.010","article-title":"The genome-enabled electronic medical record","volume":"40","author":"Hoffman","year":"2007","journal-title":"J Biomed Inform"},{"issue":"5","key":"2020110613080639400_ocz177-B22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/1556264614553922","article-title":"Genomic data in the electronic medical record: perspectives from a biobank community advisory board","volume":"9","author":"Kimball","year":"2014","journal-title":"J Empir Res Hum Res Ethics"},{"issue":"4","key":"2020110613080639400_ocz177-B23","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/gim.2012.131","article-title":"Leveraging the electronic health record to implement genomic medicine","volume":"15","author":"Kullo","year":"2013","journal-title":"Genet Med"},{"issue":"6","key":"2020110613080639400_ocz177-B24","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/clpt.2012.42","article-title":"Electronic medical records as a tool in clinical pharmacology: opportunities and challenges","volume":"91","author":"Roden","year":"2012","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"2020110613080639400_ocz177-B25","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/clpt.2010.260","article-title":"The emerging role of electronic medical records in pharmacogenomics","volume":"89","author":"Wilke","year":"2011","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"2020110613080639400_ocz177-B26","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/jamia\/ocy051","article-title":"Empowering genomic medicine by establishing critical sequencing result data flows: the eMERGE example","volume":"25","author":"Aronson","year":"2018","journal-title":"J Am Med Inform Assoc"},{"issue":"1","key":"2020110613080639400_ocz177-B27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.mayocp.2013.10.021","article-title":"Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol","volume":"89","author":"Bielinski","year":"2014","journal-title":"Mayo Clin Proc"},{"issue":"11","key":"2020110613080639400_ocz177-B28","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.mayocp.2018.06.026","article-title":"The Return of Actionable Variants Empirical (RAVE) study, a Mayo clinic genomic medicine implementation study: design and initial results","volume":"93","author":"Kullo","year":"2018","journal-title":"Mayo Clin Proc"},{"issue":"10","key":"2020110613080639400_ocz177-B29","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.amjmed.2016.04.009","article-title":"Integrating pharmacogenomics into clinical practice: promise vs reality","volume":"129","author":"St Sauver","year":"2016","journal-title":"Am J Med"},{"issue":"12","key":"2020110613080639400_ocz177-B30","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.amjmed.2017.07.012","article-title":"Challenges in ordering and interpreting pharmacogenomic tests in clinical practice","volume":"130","author":"Moyer","year":"2017","journal-title":"Am J Med"},{"key":"2020110613080639400_ocz177-B31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmoldx.2019.04.003","article-title":"Recommendations for clinical CYP2C9 Genotyping allele selection: a joint recommendation of the association for molecular pathology and College of American Pathologists","author":"Pratt","year":"2019; 21 (5): 746\u201355","journal-title":"J Mol Diagn"},{"issue":"3","key":"2020110613080639400_ocz177-B32","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jmoldx.2018.01.011","article-title":"Recommendations for clinical CYP2C19 genotyping allele selection: a report of the association for molecular pathology","volume":"20","author":"Pratt","year":"2018","journal-title":". J Mol Diagn"},{"issue":"2","key":"2020110613080639400_ocz177-B33","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2217\/14622416.7.2.247","article-title":"Clinical genomics data standards for pharmacogenetics and pharmacogenomics","volume":"7","author":"Shabo","year":"2006","journal-title":"Pharmacogenomics"}],"container-title":["Journal of the American Medical Informatics Association"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jamia\/article-pdf\/27\/1\/154\/34152401\/ocz177.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jamia\/article-pdf\/27\/1\/154\/34152401\/ocz177.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T19:18:41Z","timestamp":1604690321000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jamia\/article\/27\/1\/154\/5582701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,7]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,10,7]]},"published-print":{"date-parts":[[2020,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jamia\/ocz177","relation":{},"ISSN":["1527-974X"],"issn-type":[{"value":"1527-974X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,1]]},"published":{"date-parts":[[2019,10,7]]}}}